Consumer Discretionary • Catalog/Specialty Distribution
$120.12 ▲ +6.10
(+5.35%)
MKT CAP: $16.45B • VOL: 3.33M
52W L $56 52W H $121
W // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.46B | $11.85B | $12.00B |
| YoY Revenue Growth % | +5.1% | -1.3% | — |
| Gross Profit | $3.77B | $3.57B | $5.28B |
| Gross Margin % | 30.2% | 30.2% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $17.0M | -$461.0M | -$813.0M |
| Operating Margin % | 0.1% | -3.9% | -6.8% |
| Net Income (GAAP) | -$313.0M | -$492.0M | -$738.0M |
| EBITDA (Normalized) | $73.0M | -$402.6M | -$380.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $534.0M | $317.0M | $349.0M |
| Capital Expenditures (CapEx) | $70.0M | $73.0M | $540.1M |
| Free Cash Flow (FCF) | $464.0M | $244.0M | -$191.1M |
| FCF Margin % | 3.7% | 2.1% | -1.6% |
| Return on Invested Capital (ROIC %) | 95.0% | -45.0% | -7.4% |
| Cash & Short-Term Equivalents | $1.48B | $1.32B | $1.58B |
| Total Debt (Short + Long Term) | $3.23B | $2.88B | $3.37B |
| Total Stockholders' Equity | -$2.78B | -$2.75B | $6.91B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR W.